$ML
MONEYLION INC.

2023 Q3 Form 10-Q Financial Statement

#000095017023039411 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $110.3M $106.5M $87.34M
YoY Change 24.24% 21.98% 128.76%
Cost Of Revenue $32.80M $32.23M $29.39M
YoY Change 13.74% 9.68% 178.73%
Gross Profit $77.40M $74.31M $57.95M
YoY Change 29.19% 28.22% 109.7%
Gross Profit Margin 70.2% 69.75% 66.35%
Selling, General & Admin $41.40M $39.25M $21.54M
YoY Change -8.9% 82.24% 35.68%
% of Gross Profit 53.49% 52.82% 37.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $225.0K $283.0K $257.0K
YoY Change -29.47% 10.12% 335.59%
% of Gross Profit 0.29% 0.38% 0.44%
Operating Expenses $109.2M $108.3M $114.2M
YoY Change -3.33% -5.24% 121.57%
Operating Profit $1.101M -$1.720M -$26.91M
YoY Change -104.55% -93.61% 101.05%
Interest Expense $7.088M $7.330M $7.584M
YoY Change -10.05% -3.35% 310.17%
% of Operating Profit 643.78%
Other Income/Expense, Net $2.358M $1.257M $9.000K
YoY Change 412.61% 13866.67% -99.72%
Pretax Income -$3.710M -$27.99M -$23.05M
YoY Change -82.3% 21.42% -41.2%
Income Tax $400.0K $262.0K $16.00K
% Of Pretax Income
Net Earnings -$4.110M -$27.72M -$23.07M
YoY Change -80.44% 20.2% -45.46%
Net Earnings / Revenue -3.73% -26.02% -26.41%
Basic Earnings Per Share -$0.40 -$2.71 -$0.11
Diluted Earnings Per Share -$0.40 -$2.71 -$97.60K
COMMON SHARES
Basic Shares Outstanding 10.17M 8.798M 236.3M
Diluted Shares Outstanding 10.22M 9.234M 7.877M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.30M $96.74M $154.1M
YoY Change -25.38% -37.21% 431.77%
Cash & Equivalents $94.27M $96.74M $154.1M
Short-Term Investments
Other Short-Term Assets $6.000M $6.278M $6.856M
YoY Change 29.06% -8.43% 118.76%
Inventory
Prepaid Expenses
Receivables $158.1M $156.6M $133.4M
Other Receivables $19.10M $21.25M $17.52M
Total Short-Term Assets $277.5M $280.9M $311.8M
YoY Change -1.57% -9.91% 151.24%
LONG-TERM ASSETS
Property, Plant & Equipment $2.111M $2.348M $2.045M
YoY Change -27.11% 14.82% 331.43%
Goodwill $161.7M
YoY Change
Intangibles $180.9M $185.3M $209.2M
YoY Change -12.04% -11.46%
Long-Term Investments
YoY Change
Other Assets $51.03M $50.30M $63.16M
YoY Change -18.79% -20.37% 2150.93%
Total Long-Term Assets $234.8M $237.1M $471.9M
YoY Change -50.77% -49.76% 989.95%
TOTAL ASSETS
Total Short-Term Assets $277.5M $280.9M $311.8M
Total Long-Term Assets $234.8M $237.1M $471.9M
Total Assets $512.3M $517.9M $783.6M
YoY Change -32.49% -33.91% 368.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.60M $42.81M $50.24M
YoY Change -15.63% -14.79% 166.76%
Accrued Expenses $7.900M $8.462M $9.736M
YoY Change -15.91% -13.09% 612.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.50M $51.27M $59.98M
YoY Change -15.67% -14.52% 138.0%
LONG-TERM LIABILITIES
Long-Term Debt $194.4M $204.0M $241.3M
YoY Change -19.55% -15.43% 94.0%
Other Long-Term Liabilities $15.87M $17.09M $68.46M
YoY Change -69.27% -75.03% -6.8%
Total Long-Term Liabilities $15.87M $17.09M $309.7M
YoY Change -94.59% -94.48% 56.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.50M $51.27M $59.98M
Total Long-Term Liabilities $15.87M $17.09M $309.7M
Total Liabilities $256.3M $264.3M $369.7M
YoY Change -28.16% -28.52% 14.05%
SHAREHOLDERS EQUITY
Retained Earnings -$698.5M -$694.4M -$502.0M
YoY Change 33.57% 38.34%
Common Stock $1.000K $1.000K $24.00K
YoY Change -96.0% -95.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.700M $9.700M $9.700M
YoY Change 0.0% 0.0%
Treasury Stock Shares $32.33K $970.0K
Shareholders Equity $256.0M $253.7M $220.3M
YoY Change
Total Liabilities & Shareholders Equity $512.3M $517.9M $783.6M
YoY Change -32.49% -33.91% 368.16%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$4.110M -$27.72M -$23.07M
YoY Change -80.44% 20.2% -45.46%
Depreciation, Depletion And Amortization $225.0K $283.0K $257.0K
YoY Change -29.47% 10.12% 335.59%
Cash From Operating Activities $36.07M $35.36M -$859.0K
YoY Change -9445.08% -4216.76% -166.08%
INVESTING ACTIVITIES
Capital Expenditures $1.527M $1.638M -$2.189M
YoY Change -144.24% -174.83% 1583.85%
Acquisitions
YoY Change
Other Investing Activities -$26.45M -$33.95M -$29.08M
YoY Change 7.47% 16.77% -22.03%
Cash From Investing Activities -$27.98M -$35.59M -$31.26M
YoY Change -0.32% 13.83% -16.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -9.255M -8.356M 356.0K
YoY Change -2208.2% -2447.19% -95.59%
NET CHANGE
Cash From Operating Activities 36.07M 35.36M -859.0K
Cash From Investing Activities -27.98M -35.59M -31.26M
Cash From Financing Activities -9.255M -8.356M 356.0K
Net Change In Cash -1.158M -8.582M -31.77M
YoY Change -95.87% -72.98% 13.3%
FREE CASH FLOW
Cash From Operating Activities $36.07M $35.36M -$859.0K
Capital Expenditures $1.527M $1.638M -$2.189M
Free Cash Flow $34.55M $33.73M $1.330M
YoY Change 1026.71% 2435.71% -6.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001807846
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39346
dei Entity Registrant Name
EntityRegistrantName
MoneyLion Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-0849243
dei Entity Address Address Line1
EntityAddressAddressLine1
30 West 21st Street
dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10010
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
300-9865
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10165563
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96739000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115864000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3604000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
36235000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
5435000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
37845000
CY2023Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
188370000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31755000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24841000
CY2023Q2 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
130213000
CY2022Q4 ml Receivables Net Including Amounts Held By Vi Es
ReceivablesNetIncludingAmountsHeldByVIEs
113963000
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
156615000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
145135000
CY2023Q2 ml Enterprise Receivables
EnterpriseReceivables
21253000
CY2022Q4 ml Enterprise Receivables
EnterpriseReceivables
19017000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2348000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
185253000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
194247000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50297000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54658000
CY2023Q2 us-gaap Assets
Assets
517940000
CY2022Q4 us-gaap Assets
Assets
596342000
CY2023Q2 ml Secured Loans
SecuredLoans
84141000
CY2022Q4 ml Secured Loans
SecuredLoans
88617000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
42810000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
58129000
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
324000
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
337000
CY2023Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
119906000
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
143394000
CY2023Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
119906000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17094000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33496000
CY2023Q2 us-gaap Liabilities
Liabilities
264275000
CY2022Q4 us-gaap Liabilities
Liabilities
323973000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
173208000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
957778000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
766839000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-694414000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-657979000
CY2023Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
32333
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
32333
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
9700000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
253665000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
99161000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
517940000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596342000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
103237000
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
84823000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
193978000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
151969000
CY2023Q2 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
3304000
CY2022Q2 ml Interest Income On Loan Net
InterestIncomeOnLoanNet
2517000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
6232000
ml Interest Income On Loan Net
InterestIncomeOnLoanNet
5085000
CY2023Q2 us-gaap Revenues
Revenues
106541000
CY2022Q2 us-gaap Revenues
Revenues
87340000
us-gaap Revenues
Revenues
200210000
us-gaap Revenues
Revenues
157054000
CY2023Q2 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
25562000
CY2022Q2 ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
26981000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
42073000
ml Provision For Credit Losses On Consumer Receivables
ProvisionForCreditLossesOnConsumerReceivables
50025000
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
22572000
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
26498000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
46980000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
48541000
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
6549000
CY2022Q2 us-gaap Marketing Expense
MarketingExpense
9477000
us-gaap Marketing Expense
MarketingExpense
12941000
us-gaap Marketing Expense
MarketingExpense
20893000
CY2023Q2 ml Direct Operating Cost
DirectOperatingCost
32230000
CY2022Q2 ml Direct Operating Cost
DirectOperatingCost
29386000
ml Direct Operating Cost
DirectOperatingCost
62032000
ml Direct Operating Cost
DirectOperatingCost
50590000
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
4518000
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
6652000
us-gaap Professional Fees
ProfessionalFees
9517000
us-gaap Professional Fees
ProfessionalFees
13940000
CY2023Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5611000
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5409000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11649000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
9914000
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-11219000
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9842000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20214000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20611000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
108261000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
114245000
us-gaap Operating Expenses
OperatingExpenses
205406000
us-gaap Operating Expenses
OperatingExpenses
214514000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1720000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26905000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5196000
us-gaap Operating Income Loss
OperatingIncomeLoss
-57460000
CY2023Q2 us-gaap Interest Expense
InterestExpense
7330000
CY2022Q2 us-gaap Interest Expense
InterestExpense
7584000
us-gaap Interest Expense
InterestExpense
14841000
us-gaap Interest Expense
InterestExpense
13758000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-162000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2951000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6861000
CY2023Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6367000
CY2022Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-8480000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-3820000
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1257000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2906000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-907000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27985000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23049000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37226000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-61444000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
262000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-286000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-28401000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-23065000
us-gaap Profit Loss
ProfitLoss
-36940000
us-gaap Profit Loss
ProfitLoss
-33043000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
CY2022Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-2176000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-3204000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25056000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25241000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36250000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36247000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.20
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.66
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9234238
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9234238
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7877106
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7877106
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8944836
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8944836
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7784688
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7784688
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95491000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5250000
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-183000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
45000
CY2023Q2 ml Reversal Of Previously Accrued Dividends On Preferred Stock
ReversalOfPreviouslyAccruedDividendsOnPreferredStock
2667000
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2976000
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
174849000
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-11000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-27723000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
253665000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
99161000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10955000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-782000
ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
1914000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
304000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-45000
ml Reversal Of Previously Accrued Dividends On Preferred Stock
ReversalOfPreviouslyAccruedDividendsOnPreferredStock
690000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
2976000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
174849000
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
493000
us-gaap Net Income Loss
NetIncomeLoss
-36940000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
253665000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
233481000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5248000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
356000
CY2022Q2 ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
6440000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-2176000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23065000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
220284000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-221684000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8516000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
777000
ml Issuance Of Common Stock In Connection With Earnout And Makewhole Provisions Related To The
IssuanceOfCommonStockInConnectionWithEarnoutAndMakewholeProvisionsRelatedToThe
16718000
ml Distributions To Redeemable Noncontrolling Interests
DistributionsToRedeemableNoncontrollingInterests
8963000
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-3204000
ml Redemption Of Stock Options
RedemptionOfStockOptions
-127000
us-gaap Net Income Loss
NetIncomeLoss
-33043000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
220284000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-23065000
us-gaap Profit Loss
ProfitLoss
-36940000
us-gaap Profit Loss
ProfitLoss
-33043000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25562000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26981000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42073000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50025000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6113000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6006000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12297000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9427000
CY2023Q2 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-782000
CY2022Q2 us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-446000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-1398000
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
-705000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-162000
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2951000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6861000
CY2023Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6367000
CY2022Q2 ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-8480000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-6613000
ml Change In Fair Value Of Contingent Consideration From Mergers And Acquisitions
ChangeInFairValueOfContingentConsiderationFromMergersAndAcquisitions
-3820000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
171000
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
87000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
178000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
58000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-730000
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5250000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5248000
us-gaap Share Based Compensation
ShareBasedCompensation
10955000
us-gaap Share Based Compensation
ShareBasedCompensation
8516000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-400000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-493000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-28442000
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
211000
CY2022Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
238000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
31000
CY2023Q2 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
-1708000
CY2022Q2 ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
3310000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
2422000
ml Increase Decrease In Enterprise Receivables
IncreaseDecreaseInEnterpriseReceivables
1652000
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5610000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3686000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4360000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3020000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1156000
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3193000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8649000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
843000
CY2023Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2505000
CY2022Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1157000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4215000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2829000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35363000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-859000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38043000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9510000
CY2023Q2 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
33185000
CY2022Q2 ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
29075000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
52832000
ml Net Originations And Collections Of Finance Receivables
NetOriginationsAndCollectionsOfFinanceReceivables
51947000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1638000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2189000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2675000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3012000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18584000
CY2023Q2 ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-766000
ml Settlement Of Contingent Consideration Related To Mergers And Acquisitions
SettlementOfContingentConsiderationRelatedToMergersAndAcquisitions
-1116000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35589000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31264000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56623000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-73543000
CY2023Q2 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
5000000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
24028000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
375000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-24000000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
10000000
ml Borrowings From Secured Lenders
BorrowingsFromSecuredLenders
69300000
CY2023Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
154000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
154000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1625000
CY2023Q2 ml Payments For Automatic Conversion Of Redeemable Convertible Preferred Stock
PaymentsForAutomaticConversionOfRedeemableConvertiblePreferredStock
-3007000
ml Payments For Automatic Conversion Of Redeemable Convertible Preferred Stock
PaymentsForAutomaticConversionOfRedeemableConvertiblePreferredStock
-3007000
CY2023Q2 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-183000
CY2022Q2 ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
356000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
-782000
ml Proceeds From Payments For Issuance Of Common Stock Related To Exercise Of Stock Options And Warrants
ProceedsFromPaymentsForIssuanceOfCommonStockRelatedToExerciseOfStockOptionsAndWarrants
777000
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8356000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
356000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32955000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54049000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8582000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31767000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51535000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29004000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110756000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
248987000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153709000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246224000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217220000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102174000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217220000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
7043000
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
7272000
us-gaap Interest Paid Net
InterestPaidNet
14508000
us-gaap Interest Paid Net
InterestPaidNet
12262000
CY2023Q2 ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
45000
ml Voluntary Conversion Of Preferred Stock To Common Stock
VoluntaryConversionOfPreferredStockToCommonStock
45000
CY2023Q2 ml Automatic Conversion Of Redeemable Convertible Preferred Stock To Common Stock
AutomaticConversionOfRedeemableConvertiblePreferredStockToCommonStock
174849000
ml Automatic Conversion Of Redeemable Convertible Preferred Stock To Common Stock
AutomaticConversionOfRedeemableConvertiblePreferredStockToCommonStock
174849000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
CY2022Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-2176000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-3204000
CY2023Q2 ml Issuance Of Common Stock To Settle Accrued Dividends On Preferred Stock And Preferred Stock Equivalents
IssuanceOfCommonStockToSettleAccruedDividendsOnPreferredStockAndPreferredStockEquivalents
3280000
ml Issuance Of Common Stock To Settle Accrued Dividends On Preferred Stock And Preferred Stock Equivalents
IssuanceOfCommonStockToSettleAccruedDividendsOnPreferredStockAndPreferredStockEquivalents
3280000
CY2023Q2 ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
1744000
ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
1864000
ml Equity Issued As Consideration For Mergers And Acquisitions
EquityIssuedAsConsiderationForMergersAndAcquisitions
202610000
CY2023Q2 ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
1000
CY2022Q2 ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
6440000
ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
1914000
ml Equity Issued As Settlement Of Contingent Consideration Related To Malka Acquisitions
EquityIssuedAsSettlementOfContingentConsiderationRelatedToMalkaAcquisitions
16718000
CY2023Q2 ml Equity Issued As Settlement Of Contingent Consideration Related To Engine Acquisition
EquityIssuedAsSettlementOfContingentConsiderationRelatedToEngineAcquisition
1440000
ml Equity Issued As Settlement Of Contingent Consideration Related To Engine Acquisition
EquityIssuedAsSettlementOfContingentConsiderationRelatedToEngineAcquisition
1440000
ml Contingent Consideration Issued Related To Mergers And Acquisitions
ContingentConsiderationIssuedRelatedToMergersAndAcquisitions
45336000
CY2022Q2 ml Lease Liabilities Incurred In Exchange For Operating Rightofuse Assets
LeaseLiabilitiesIncurredInExchangeForOperatingRightofuseAssets
990000
ml Lease Liabilities Incurred In Exchange For Operating Rightofuse Assets
LeaseLiabilitiesIncurredInExchangeForOperatingRightofuseAssets
7568000
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-30 reverse stock split
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
At the effective time of the Reverse Stock Split, every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock, and the total number of shares of Class A Common Stock authorized for issuance was reduced by a corresponding proportion from 2,000,000,000 shares to 66,666,666 shares.
us-gaap Conversion Of Stock Type Of Stock Converted
ConversionOfStockTypeOfStockConverted
every 30 shares of Class A Common Stock either issued and outstanding or held as treasury stock were automatically reclassified into one new share of Class A Common Stock
CY2023Q2 ml Service And Subscription Fees
ServiceAndSubscriptionFees
66268000
CY2022Q2 ml Service And Subscription Fees
ServiceAndSubscriptionFees
50768000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
128706000
ml Service And Subscription Fees
ServiceAndSubscriptionFees
97162000
CY2023Q2 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
3304000
CY2022Q2 ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
2517000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
6232000
ml Net Interests Income On Finance Receivables
NetInterestsIncomeOnFinanceReceivables
5085000
CY2023Q2 ml Total Consumer Revenues
TotalConsumerRevenues
69572000
CY2022Q2 ml Total Consumer Revenues
TotalConsumerRevenues
53285000
ml Total Consumer Revenues
TotalConsumerRevenues
134938000
ml Total Consumer Revenues
TotalConsumerRevenues
102247000
CY2023Q2 ml Enterprise Service Revenues
EnterpriseServiceRevenues
36969000
CY2022Q2 ml Enterprise Service Revenues
EnterpriseServiceRevenues
34055000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
65272000
ml Enterprise Service Revenues
EnterpriseServiceRevenues
54807000
CY2023Q2 us-gaap Revenues
Revenues
106541000
CY2022Q2 us-gaap Revenues
Revenues
87340000
us-gaap Revenues
Revenues
200210000
us-gaap Revenues
Revenues
157054000
CY2023Q2 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2022Q2 ml Fair Value Assets Transfer Amount Between Levels
FairValueAssetsTransferAmountBetweenLevels
0
CY2023Q2 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2022Q2 ml Fair Value Liabilities Transfer Amount Between Levels
FairValueLiabilitiesTransferAmountBetweenLevels
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
136760000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
CY2023Q2 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
366000
CY2022Q2 ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
498000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
673000
ml Net Charge Offs Of Accrued Interest Income
NetChargeOffsOfAccruedInterestIncome
1046000
CY2023Q2 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
77433000
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
73451000
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
92972000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
77688000
CY2023Q2 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
170405000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
151139000
CY2023Q2 ml Fees Receivables
FeesReceivables
13286000
CY2022Q4 ml Fees Receivables
FeesReceivables
14019000
CY2023Q2 ml Subscription Receivables
SubscriptionReceivables
3250000
CY2022Q4 ml Subscription Receivables
SubscriptionReceivables
3419000
CY2023Q2 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
123000
CY2022Q4 ml Deferred Costs Origination Costs Amount
DeferredCostsOriginationCostsAmount
331000
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
1306000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1068000
CY2023Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
188370000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
169976000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5030000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5121000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2682000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2145000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2348000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2976000
CY2023Q2 us-gaap Depreciation
Depreciation
283000
CY2022Q2 us-gaap Depreciation
Depreciation
257000
us-gaap Depreciation
Depreciation
587000
us-gaap Depreciation
Depreciation
487000
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
163360000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
136760000
CY2022Q4 us-gaap Goodwill
Goodwill
26600000
ml Goodwill Impaired Impairment Loss
GoodwillImpairedImpairmentLoss
26721000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
26721000
ml Goodwill Gross Other Increase Decrease
GoodwillGrossOtherIncreaseDecrease
121000
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
121000
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
163481000
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
163481000
CY2023Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
40053000
CY2022Q4 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
41495000
CY2023Q2 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1636000
CY2022Q4 ml Intangible Assets Work In Progress
IntangibleAssetsWorkInProgress
1812000
CY2023Q2 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2022Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
160500000
CY2023Q2 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
15960000
CY2022Q4 us-gaap Finite Lived Trade Names Gross
FiniteLivedTradeNamesGross
16620000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32896000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
26180000
CY2023Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
185253000
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
194247000
CY2023Q2 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
1689000
CY2022Q2 ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
2028000
ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
2851000
ml Internally Developed Software Cost Capitalized
InternallyDevelopedSoftwareCostCapitalized
2786000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5830000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5749000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11710000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8940000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
11646000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
23245000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
23245000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
23245000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22674000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
79562000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
183617000
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
32663000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
32881000
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
6278000
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
8804000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8019000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9123000
CY2023Q2 ml Others Accrued Assets
OthersAccruedAssets
3337000
CY2022Q4 ml Others Accrued Assets
OthersAccruedAssets
3850000
CY2023Q2 us-gaap Other Assets
OtherAssets
50297000
CY2022Q4 us-gaap Other Assets
OtherAssets
54658000
ml Exceeds Aggregate Principal Amount Percentage
ExceedsAggregatePrincipalAmountPercentage
0.90
CY2023Q2 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
859000
CY2022Q4 ml Unamortized Discounts And Debt Issuance Costs
UnamortizedDiscountsAndDebtIssuanceCosts
1383000
CY2023Q2 us-gaap Secured Debt
SecuredDebt
84141000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
88617000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2094000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2606000
CY2023Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
119906000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
143394000
us-gaap Debt Instrument Description
DebtInstrumentDescription
The interest rate as of June 30, 2023 on the Term A-1 Loans and Term A-2 Loans was 14.26% and 14.00%, respectively.
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
785000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
748000
us-gaap Operating Lease Cost
OperatingLeaseCost
1581000
us-gaap Operating Lease Cost
OperatingLeaseCost
1368000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1647000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3095000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2663000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1268000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
904000
CY2023Q2 ml Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
768000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10345000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1883000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8462000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.118
CY2023Q2 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
90410000
CY2022Q4 us-gaap Deferred Taxes Business Combination Valuation Allowance Available To Reduce Goodwill And Intangible Assets
DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceGoodwillAndIntangibleAssets
84952000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5500000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-6800000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
763400000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
786600000
us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
1200000
ml Current Carryforwards Expiration Term
CurrentCarryforwardsExpirationTerm
If not used, the current carryforwards will expire beginning in 2034.
CY2022Q1 ml Annual Limitation Amount Per Year
AnnualLimitationAmountPerYear
8200000
CY2022Q1 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
330700000
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Company's annual limitation is expected to be increased in the first five years
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
121400000
CY2023Q2 ml Net Operating Losses Subject To Limitation
NetOperatingLossesSubjectToLimitation
3800000
CY2023Q2 ml Net Unrealized Built In Gains
NetUnrealizedBuiltInGains
265200000
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
87800000
CY2023Q2 ml Net Operating Losses Available
NetOperatingLossesAvailable
3100000
CY2023Q2 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
CY2023Q2 ml Net Operating Losses Generated
NetOperatingLossesGenerated
55000000
CY2023Q2 ml Net Operating Loss Carryforwards Solely Subject To Limitation
NetOperatingLossCarryforwardsSolelySubjectToLimitation
58100000
CY2023Q2 ml Net Operating Losses Restricted
NetOperatingLossesRestricted
6000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
us-gaap Preferred Stock Conversion Basis
PreferredStockConversionBasis
Shares of Series A Preferred Stock were convertible into shares of Class A Common Stock on a one-for-thirty basis, subject to customary anti-dilution adjustments.
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5250000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5248000
us-gaap Share Based Compensation
ShareBasedCompensation
10955000
us-gaap Share Based Compensation
ShareBasedCompensation
8516000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-27723000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-23065000
us-gaap Profit Loss
ProfitLoss
-36940000
us-gaap Profit Loss
ProfitLoss
-33043000
CY2023Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
2667000
CY2022Q2 ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-2176000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
690000
ml Reversal Of Previously Accruedaccrued Dividends On Redeemable Convertible Preferred Stocks
ReversalOfPreviouslyAccruedaccruedDividendsOnRedeemableConvertiblePreferredStocks
-3204000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25056000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25241000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36250000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36247000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9234238
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9234238
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7877106
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7877106
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8944836
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8944836
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7784688
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7784688
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.66
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3885324
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3885324
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4444221
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4444221
CY2023Q2 ml Cash Paid To Equityholders
CashPaidToEquityholders
14514000
CY2023Q2 ml Shares Exchange
SharesExchange
8883228
CY2023Q2 ml Common Stock Option To Acquire
CommonStockOptionToAcquire
196728
CY2023Q2 ml Common Stock Value Vested Option
CommonStockValueVestedOption
8960000
CY2023Q2 ml Business Combination Purchase Price Value
BusinessCombinationPurchasePriceValue
271096000
us-gaap Repayments Of Debt
RepaymentsOfDebt
5703000
CY2023Q2 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
2868000
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
8000000
ml Payment Related To Contingent Consideration To Equity Holders And Advisors
PaymentRelatedToContingentConsiderationToEquityHoldersAndAdvisors
459000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
166153000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-8971000
CY2022Q4 ml Unsettled Restricted Shares Payable
UnsettledRestrictedSharesPayable
2444000
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
-180000
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
11057000

Files In Submission

Name View Source Status
0000950170-23-039411-index-headers.html Edgar Link pending
0000950170-23-039411-index.html Edgar Link pending
0000950170-23-039411.txt Edgar Link pending
0000950170-23-039411-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ml-20230630.htm Edgar Link pending
ml-20230630.xsd Edgar Link pending
ml-ex31_1.htm Edgar Link pending
ml-ex31_2.htm Edgar Link pending
ml-ex32_1.htm Edgar Link pending
ml-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
ml-20230630_pre.xml Edgar Link unprocessable
ml-20230630_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ml-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ml-20230630_cal.xml Edgar Link unprocessable
ml-20230630_lab.xml Edgar Link unprocessable